SCHEMBL9681376

SCHEMBL9681376

Nc1cc(Cl)ccc1NCc1ccc2ccccc2c1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.46
MEN1 O00255 1/20 0.46
ALPG P10696 1/20 0.46
KMT2A Q03164 1/20 0.46
CYP2A6 P11509 1/20 0.46
LMNA P02545 1/20 0.46
HTT P42858 1/20 0.46
MC5R P33032 4/20 0.45
MC4R P32245 3/20 0.45
MC3R P41968 2/20 0.43
HDAC8 Q9BY41 1/20 0.42
INSR P06213 1/20 0.41
IGF1R P08069 1/20 0.41
FFAR1 O14842 1/20 0.41
MC1R Q01726 1/20 0.41
ROCK1 Q13464 1/20 0.41
MRGPRX4 Q96LA9 1/20 0.40
APP P05067 2/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11274390 0.83 PKM (0.52) MAPTLMNAMRGPRX4APP
SCHEMBL9683129 0.82 MAPT (0.47) MAPTMEN1KMT2AHDAC8APP
SCHEMBL9683512 0.80 TP53 (0.46) FFAR1MRGPRX4
SCHEMBL11569274 0.77 ALDH1A1 (0.49) MAPTMEN1KMT2A
SCHEMBL9682901 0.77 MAPT (0.43) MAPTMEN1KMT2AHDAC8APP
SCHEMBL9683100 0.77 MAPT (0.67) MAPTMEN1ALPGKMT2ALMNA
SCHEMBL9683167 0.77 HTT (0.51) MAPTMEN1KMT2ALMNAHTT
SCHEMBL27527525 0.76 FFAR1 (0.60) MEN1KMT2ACYP2A6MC5RMC4R
Hydrochloric Acid SCHEMBL6419281 0.75 FFAR1 (0.58) MEN1KMT2ACYP2A6MC5RMC4R
SCHEMBL6696440 0.75 INSR (0.56) MAPTMEN1ALPGKMT2AMC5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5128359-A Benzimidazole and azabenzimidazole derivatives which are thromboxane receptor antagonists, their methods of preparation LABORATOIRES UPSA (FR) 1992-07-07 US disclosed
US-5124336-A Cardiovascular disorders LABORATOIRES UPSA (FR) 1992-06-23 US disclosed